NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX)

CUSIP: 64125C109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
99,963,154
Total 13F shares
99,370,279
Share change
+2,382,655
Total reported value
$14,052,588,678
Put/Call ratio
174%
Price per share
$141.83
Number of holders
720
Value change
+$319,161,027
Number of buys
385
Number of sells
259

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2025

As of 31 Dec 2025, NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by 720 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,370,279 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Dodge & Cox, JPMORGAN CHASE & CO, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 720 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.